<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=8805630" created="22/11/2006" creator="Junko Matsuura"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>8805630</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="A1" sem="Protein_family_or_group">Multifactor cis</term>-dominant <term id="T40" sem="Other">negative regulation</term> of <term id="T2" lex="IL-2_gene_expression" sem="Other"><term id="T3" lex="IL-2_gene" sem="DNA_domain_or_region"><term id="T4" lex="IL-2" sem="Protein_molecule">IL-2</term> gene</term> expression</term> in <term id="T5" lex="anergized_T_cell" sem="Cell_natural">anergized T cells</term>.</sentence>
<event KT="Other" id="E1">
<type class="Gene_expression"/>
<theme idref="T3"/>
<clue>Multifactor cis-dominant negative regulation of IL-2 gene <clueType>expression</clueType> in anergized T cells.</clue>
</event>
<event KT="Investigation" id="E2">
<type class="Negative_regulation"/>
<theme idref="E1"/>
<cause idref="A1"/>
<clue>Multifactor cis-<clueType>dominant negative regulation</clueType> <linkTheme>of</linkTheme> IL-2 gene expression <clueLoc>in anergized T cells</clueLoc>.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">The molecular mechanism underlying <term id="T6" lex="IL-2_transcriptional_blockade" sem="Other"><term id="T7" lex="IL-2" sem="Protein_molecule">IL-2</term> transcriptional blockade</term> in <term id="T8" lex="anergic_T_cell_clone" sem="Cell_cultured">anergic T cell clones</term> is not fully understood.</sentence>
<event KT="Other" id="E3">
<type class="Negative_regulation"/>
<theme idref="T7"/>
<clue>The molecular mechanism underlying IL-2 <clueType>transcriptional blockade</clueType> <clueLoc>in anergic T cell clones</clueLoc> is not fully understood.</clue>
</event>
<sentence id="S3">To examine whether an active <term id="T1" sem="Other">negative regulatory process</term> occurs, we created a <term id="T9" lex="reporter_construct" sem="DNA_molecule">reporter construct</term> containing as an <term id="T10" lex="enhancer" sem="DNA_domain_or_region">enhancer</term> four copies of the <term id="T11" lex="NF-AT_site" sem="DNA_domain_or_region">NF-AT site</term> and one copy of the <term id="T12" lex="octamer_site" sem="DNA_domain_or_region">octamer site</term> (<term id="T13" lex="4X_NF-AT-Oct" sem="DNA_domain_or_region">4X NF-AT-Oct</term>).</sentence>
<sentence id="S4">This construct was only slightly reduced (1.3-fold) in its expression when stimulated under <term id="T14" lex="anergic_conditions" sem="Other">anergic conditions</term>, while a whole <term id="T15" sem="DNA_molecule"><term id="T42" sem="Multicellular_organism_natural">mouse</term> <term id="T16" lex="IL-2_enhancer" sem="DNA_domain_or_region"><term id="T17" lex="IL-2" sem="Protein_molecule">IL-2</term> enhancer</term> construct</term> showed a <term id="T41" sem="Other">reduction</term> of 4.3-fold.</sentence>
<event id="E4">
<type class="Physiological_process"/>
<theme idref="T5"/>
<clue>This construct was only slightly reduced (1.3-fold) in its expression when <clueType>stimulated</clueType> under anergic conditions, while a whole mouse IL-2 enhancer construct showed a reduction of 4.3-fold.</clue>
<comment>NO COREFTHEME</comment></event>
<event id="E5">
<type class="Gene_expression"/>
<theme idref="T13"/>
<clue>This construct was only slightly reduced (1.3-fold) in <corefTheme>its</corefTheme> <clueType>expression</clueType> when stimulated under anergic conditions, while a whole mouse IL-2 enhancer construct showed a reduction of 4.3-fold.</clue>
</event>
<event id="E6">
<type class="Positive_regulation"/>
<theme idref="E5"/>
<cause idref="E4"/>
<clue>This construct was only slightly reduced (1.3-fold) in its expression <linkCause>when</linkCause> stimulated under anergic conditions, while a whole mouse IL-2 enhancer construct showed a reduction of 4.3-fold.</clue>
<comment>NO CLUETYPE</comment></event>
<event Manner="Low" id="E7">
<type class="Negative_regulation"/>
<theme idref="E6"/>
<clue>This construct was only <clueManner>slightly</clueManner> <clueType>reduced</clueType> (<clueManner>1.3-fold</clueManner>) in its expression when stimulated under anergic conditions, while a whole mouse IL-2 enhancer construct showed a reduction of 4.3-fold.</clue>
</event>
<event id="E8">
<type class="Gene_expression"/>
<theme idref="T15"/>
<clue>This construct was only slightly reduced (1.3-fold) in its <clueType>expression</clueType> when stimulated under anergic conditions, while a whole mouse IL-2 enhancer construct showed a reduction of 4.3-fold.</clue>
</event>
<event id="E9">
<type class="Positive_regulation"/>
<theme idref="E8"/>
<cause idref="E4"/>
<clue>This construct was only slightly reduced (1.3-fold) in its expression <linkCause>when</linkCause> stimulated under anergic conditions, while a whole mouse IL-2 enhancer construct showed a reduction of 4.3-fold.</clue>
<comment>NO CLUETYPE</comment></event>
<event KT="Analysis" Manner="High" id="E10">
<type class="Negative_regulation"/>
<theme idref="E9"/>
<clue>This construct was only slightly reduced (1.3-fold) in its expression when stimulated under anergic conditions, while a whole mouse IL-2 enhancer construct <clueKT>showed</clueKT> a <clueType>reduction</clueType> of <clueManner>4.3-fold</clueManner>.</clue>
</event>
<sentence id="S5"><term id="T43" sem="Other">Addition</term> of the <term id="T18" lex="-176_to_-96_sequence" sem="DNA_domain_or_region">-176 to -96 sequence</term> to the <term id="T19" lex="4X_NF-AT-Oct_construct" sem="DNA_molecule"><term id="T20" lex="4X_NF-AT-Oct" sem="DNA_domain_or_region">4X NF-AT-Oct</term> construct</term> did not impart the ability to be affected by <term id="A3" sem="Other">anergy</term>, but <term id="T44" sem="Other">addition</term> of the <term id="T21" lex="-236_to_-96_sequence" sem="DNA_domain_or_region">-236 to -96 sequence</term> did, demonstrating that <term id="T45" sem="Other">anergy</term> is an active <term id="T46" sem="Other">inhibitory process</term> and that more than the presence of the <term id="T22" lex="-150_AP-1_binding_site" sem="DNA_domain_or_region">-150 AP-1 binding site</term> (<term id="T23" lex="-152_to_-147" sem="DNA_domain_or_region">-152 to -147</term>) is required to mediate the effect.</sentence>
<event KT="Method" id="E11">
<type class="Mutagenesis"/>
<theme idref="T19"/>
<theme idref="T18"/>
<clue><clueType>Addition</clueType> <linkTheme>of</linkTheme> the -176 to -96 sequence <linkTheme>to</linkTheme> the 4X NF-AT-Oct construct did not impart the ability to be affected by anergy, but addition of the -236 to -96 sequence did, demonstrating that anergy is an active inhibitory process and that more than the presence of the -150 AP-1 binding site (-152 to -147) is required to mediate the effect.</clue>
<comment>Artificial</comment></event>
<event CL="L2" KT="Analysis" id="E12">
<type class="Regulation"/>
<theme idref="E5"/>
<cause idref="A3"/>
<clue>Addition of the -176 to -96 sequence to the 4X NF-AT-Oct construct did not impart the <clueKT><clueCL>ability</clueCL></clueKT> to be <clueType>affected</clueType> <linkCause>by</linkCause> anergy, but addition of the -236 to -96 sequence did, demonstrating that anergy is an active inhibitory process and that more than the presence of the -150 AP-1 binding site (-152 to -147) is required to mediate the effect.</clue>
<comment>NO COREFTHEME</comment></event>
<event Polarity="Negative" assertion="non-exist" id="E13">
<type class="Positive_regulation"/>
<theme idref="E12"/>
<cause idref="E11"/>
<clue>Addition of the -176 to -96 sequence to the 4X NF-AT-Oct construct did <cluePolarity>not</cluePolarity> <clueType>impart</clueType> the ability to be affected by anergy, but addition of the -236 to -96 sequence did, demonstrating that anergy is an active inhibitory process and that more than the presence of the -150 AP-1 binding site (-152 to -147) is required to mediate the effect.</clue>
</event>
<event KT="Method" id="E14">
<type class="Artificial_process"/>
<theme idref="T19"/>
<theme idref="T21"/>
<clue>Addition of the -176 to -96 sequence <linkTheme>to</linkTheme> the 4X NF-AT-Oct construct did not impart the ability to be affected by anergy, but <clueType>addition</clueType> <linkTheme>of</linkTheme> the -236 to -96 sequence did, demonstrating that anergy is an active inhibitory process and that more than the presence of the -150 AP-1 binding site (-152 to -147) is required to mediate the effect.</clue>
</event>
<event id="E15">
<type class="Positive_regulation"/>
<theme idref="E12"/>
<cause idref="E14"/>
<clue>Addition of the -176 to -96 sequence to the 4X NF-AT-Oct construct did not <clueType>impart</clueType> the ability to be affected by anergy, but addition of the -236 to -96 sequence did, demonstrating that anergy is an active inhibitory process and that more than the presence of the -150 AP-1 binding site (-152 to -147) is required to mediate the effect.</clue>
</event>
<event KT="Analysis" id="E16">
<type class="Positive_regulation"/>
<theme idref="E12"/>
<cause idref="T22"/>
<clue>Addition of the -176 to -96 sequence to the 4X NF-AT-Oct construct did not impart the ability to be affected by anergy, but addition of the -236 to -96 sequence did, <clueKT>demonstrating</clueKT> that anergy is an active inhibitory process and that more than the presence of the -150 AP-1 binding site (-152 to -147) is <clueType>required</clueType> to mediate <corefTheme>the effect</corefTheme>.</clue>
</event>
<sentence id="S6"><term id="T24" lex="mutational_study" sem="Other">Mutational studies</term> of the <term id="T25" lex="-236_to_-96_sequence" sem="DNA_domain_or_region">-236 to -96 sequence</term> indicated that the presence of both the <term id="T26" lex="-130_AP-1-like_site" sem="DNA_domain_or_region">-130 AP-1-like site</term> (<term id="T27" lex="-187_to_-181" sem="DNA_domain_or_region">-187 to -181</term>) and the <term id="T28" lex="-150_proximal_AP-1_site" sem="DNA_domain_or_region">-150 proximal AP-1 site</term> were necessary to observe <term id="A4" sem="Other">anergy</term>.</sentence>
<event CL="L2" KT="Analysis" id="E17">
<type class="Positive_regulation"/>
<theme idref="A4"/>
<cause idref="T26"/>
<cause idref="T28"/>
<clue><clueExperiment>Mutational studies of the -236 to -96 sequence</clueExperiment> <clueKT><clueCL>indicated</clueCL></clueKT> that the presence of both the -130 AP-1-like site (-187 to -181) and the -150 proximal AP-1 site were <clueType>necessary</clueType> <linkTheme>to</linkTheme> observe anergy.</clue>
</event>
<sentence id="S7">Because the <term id="T29" lex="-180_site" sem="DNA_domain_or_region">-180 site</term> is not required for <term id="T30" lex="trans-activation" sem="Other">trans-activation</term>, it was possible to confirm by mutation in the normal <term id="T31" lex="mouse_IL-2_enhancer" sem="DNA_domain_or_region"><term id="T47">mouse</term> <term id="T32" lex="IL-2_enhancer" sem="DNA_domain_or_region"><term id="T33" lex="IL-2" sem="Protein_molecule">IL-2</term> enhancer</term></term> that this site is absolutely essential for <term id="T34" lex="anergy_induction" sem="Other"><term id="A6" sem="Other">anergy</term> induction</term>.</sentence>
<event KT="Fact" Polarity="Negative" id="E18">
<type class="Positive_regulation"/>
<theme idref="T30"/>
<cause idref="T29"/>
<clue>Because the -180 site is <cluePolarity>not</cluePolarity> <clueType>required</clueType> <linkTheme>for</linkTheme> trans-activation, it was possible to confirm by mutation in the normal mouse IL-2 enhancer that this site is absolutely essential for anergy induction.</clue>
</event>
<event KT="Other" id="E19">
<type class="Positive_regulation"/>
<theme idref="A6"/>
<clue>Because the -180 site is not required for trans-activation, it was possible to confirm by mutation in the normal mouse IL-2 enhancer that this site is absolutely essential for anergy <clueType>induction</clueType>.</clue>
</event>
<event CL="L1" KT="Analysis" id="E20">
<type class="Positive_regulation"/>
<theme idref="E19"/>
<cause idref="T29"/>
<clue>Because the -180 site is not required for trans-activation, it was <clueCL>possible</clueCL> to <clueKT>confirm</clueKT> <clueExperiment>by mutation in the normal mouse IL-2 enhancer</clueExperiment> that this site is absolutely <clueType>essential</clueType> <linkTheme>for</linkTheme> anergy induction.</clue>
</event>
<event KT="Method" id="E21">
<type class="Mutagenesis"/>
<theme idref="T31"/>
<clue>Because the -180 site is not required for trans-activation, it was possible to confirm by <clueType>mutation</clueType> <linkTheme>in</linkTheme> the normal mouse IL-2 enhancer that this site is absolutely essential for anergy induction.</clue>
<comment>Artificial</comment></event>
<sentence id="S8">The simplest model to explain these results is that <term id="T35" lex="anergy" sem="Other">anergy</term> is mediated by a <term id="A7" sem="Protein_complex">complex of multiple <term id="T36" lex="transcription_factor" sem="Protein_family_or_group">transcription factors</term></term> that exert a <term id="T49" sem="Protein_family_or_group">cis</term>-acting dominant <term id="T48" sem="Other">negative regulatory effect</term> on the <term id="T50" sem="Other">trans-activation</term> of the <term id="T38" lex="IL-2_gene" sem="DNA_domain_or_region"><term id="T39" lex="IL-2" sem="Protein_molecule">IL-2</term> gene</term>.</sentence>
<event KT="Other" id="E22">
<type class="Positive_regulation"/>
<theme idref="T38"/>
<clue>The simplest model to explain these results is that anergy is mediated by a complex of multiple transcription factors that exert a cis-acting dominant negative regulatory effect on the <clueType>trans-activation</clueType> <linkTheme>of</linkTheme> the IL-2 gene.</clue>
</event>
<event KT="Other" id="E23">
<type class="Negative_regulation"/>
<theme idref="E22"/>
<clue>The simplest model to explain these results is that anergy is mediated by a complex of multiple transcription factors that exert a cis-acting <clueType>dominant negative regulatory effect</clueType> <linkTheme>on</linkTheme> the trans-activation of the IL-2 gene.</clue>
</event>
<event KT="Other" id="E24">
<type class="Positive_regulation"/>
<theme idref="E23"/>
<cause idref="A7"/>
<clue>The simplest model to explain these results is that anergy is mediated by a complex of multiple transcription factors that <clueType>exert</clueType> a cis-acting dominant negative regulatory effect on the trans-activation of the IL-2 gene.</clue>
<comment>TPS: A7</comment></event>
<event KT="Analysis" id="E25">
<type class="Positive_regulation"/>
<theme idref="T35"/>
<cause idref="E24"/>
<clue>The simplest model to <clueKT>explain</clueKT> these results is that anergy is <clueType>mediated</clueType> <linkCause>by</linkCause> a complex of multiple transcription factors that exert a cis-acting dominant negative regulatory effect on the trans-activation of the IL-2 gene.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
